Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (Taxol) in murine macrophages

Infection and Immunity

Volumn 66, Issue 10, 1998, Pages 4669-4675

  Zaks Zilberman, Meirav ^a   Salkowski, Cindy A ^a   Elsasser, Theodore ^b   Cuttitta, Frank ^c   Vogel, Stefanie N ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BACTERIUM LIPOPOLYSACCHARIDE; MESSENGER RNA; PACLITAXEL;

ANIMAL CELL; ANTIGENICITY; ARTICLE; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; OUTER MEMBRANE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEPSIS; SEPTIC SHOCK; TOXOPLASMA GONDII;

EID: 0031663474     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.10.4669-4675.1998     Document Type: Article

References (50)

1. Abraham, E., R. Wunderfnk, H. Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R. P. Wenzel, R. Balk, and R. Allred. 1995. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome, A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Studs Group. JAMA 273:934-941.
2. Atwell. G. J., G. W. Rewcastle, B. C. Baguley, and W. A. Denny. 1990. Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-suhstituted 9-oxoxanthene-4-acetic acids. J. Med. Chem. 33:1375-1379.
3. Barber, S. A., M. J. Fultz, C. A. Salkowski, and S. N. Vogel. 1995. Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2. and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63:601-608.
4. Bogdan, C., and A. Ding. 1442. Taxol. a microtubule-stabilizing antineoplustic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J. Leukocyte Biol. 52:119-121.
5. Bone, R. C. 1991. A critical evaluation of new agents for the treatment of sepsis. JAMA 266:1686-1691.
6. Courtois, G., S. T. Whiteside, C. H. Sibley, and A. Israel. 1997. Characterization of a mutant cell line that docs not activate NF-kB in response to multiple stimuli. Mol. Cell. Biol. 17:1441-1449.
7. Dalton. D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
8. Ding, A. H., F. Porteu, E. Sanchez, and C. F. Nathan. 1490. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248:370-372.
9. Fultz, M. J., S. A. Barber, C. W. Dieffenhach, and S. N. Vogel. 1993. Induction of IFN-gamma in macrophages by lipopolysaecharide. Int. Immunol. 5:1383-1392.
10. Hamilton, T. A., and J. A. Major. 1996. Oxidized LDL potentiates LPS- induced transcription of the chemokine KC gene. J. Leukocyte Biol. 59:940-947.
11. d, macrophages. Mol. Med. 1:428-435.
12. Hogan, M. M., and S. N. Vogel. 1987. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed. C3H/HeJ macrophages to a fully tumoricidal state. J. Immunol. 139:3697-3702.
13. d) macrophages requires the presence of lipid A-associated proteins. J. Immunol. 141:4196-4202.
14. 13a. Institute of Laboratory Animal Resources. 1985. Guide for the care and use of laboratory animals. National Research Council DHEW publication no. (NIH) 85-23. Institute of Laboratory Resources. Washington, D.C.
15. Ishimitsu, T., T. Nlshlklml, Y. Saito, K. Kitamura, T. Eto, K. Kangawa, H. Matsuo, T. Omae, and H. Matsuoka. 1994. Plasma levels of adrenomedullin. a newly identified hypotensive peptide. in patients with hypertension and renal failure. J. Clin. Invest. 94:2158-2161.
16. Ishiyama, V., K. Kitemura, Y. Ichiki, S. Nakamura, O. Kida, K. Kangawa, and T. Eto. 1993. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin. in rats. Eur. J. Pharmacol. 241:271-273.
17. Jin, F.-Y., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88:417-426.
18. Kirikae, T., I. Ojima, F. Kirikae, Z. Ma, S. D. Kuduk, J. C. Slater, C. S. Takeuchi, P. Y. Bounaud, and M. Nakano. 1996. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages. Biochem. Biophys. Res. Commun. 227:227-235.
19. Kitamura, K., Y. Ichiki, M. Tanaka, M. Kawamoto, J. Emura, S. Sakakibara, K. Kangawa, H. Matsuo, and T. Eto. 1994. Immunoreactive adrenomedullin in human plasma. FEBS Lett. 341:288-290.
20. Kitamura, K., K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura, H. Matsuo, and T. Eto. 1993. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-560.
21. Kitamura, K., J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto. 1993. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:720-725. (Er-ratum. 202:643, 1994.)
22. LI, Z. Y., C. L. Manthey, P. Y. Perera, A. Sher, and S. N. Vogel. 1994. Taxoplasrna gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages. Infect. Immun. 62:3434-3440.
23. Manthey, C. L., M. E. Brandes, P. Y. Perera, and S. N. Vogel. 1992. Taxol increases steady-state levels of lipopolysacchwride-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J. Immunol. 149:2459-2465.
24. d) macrophages. J. Immunol. 153:2653-2663.
25. Manthey, C. L., P. Y. Perera, C. A. Salkowski, and S. N. Vogel. 1994. Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol. 152:825-831.
26. Manthey, C. L., and S. N. Vogel. 1992. The role of cytokines in host responses to endotoxin. Rev, Med. Microbiol. 3:72-79.
27. Martinez, A., T. H. Elsasser, C. Muro-Cacho, T. W. Moody, M. J. Miller, C. J. Maori, and F. Cuttitta. 1997. Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument. Endocrinology 138:5597-5604.
28. Martinez, A., M. J. Miller, E. J. Unsworth, J. M. Siegfried, and F. Cuttitta. 1995. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136:4099-4105.
29. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6:2363-2372.
30. Miller, M. J., A. Martinez, E. J. Unsworth, C. J. Thiele, T. W. Moody, T. Elsasser, and F. Cuttitta. 1996. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J. Biol. Chem. 271:23345-23351.
31. Minnard, E. A., J. Shou, H. Naama, A. Cech, H. Gallagher, and J. M. Daly. 1994. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch. Surg. 129:142-147.
32. Morrison, D. C., and L. Leive. 1975. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J. Biol. Chem. 250:2911-2919.
33. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hageman, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552.
34. Parker, M. M., J. H. Shelhamer, C. Natanson, D. W. Alling, and J. E. Parrillo. 1987. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit. Care Med. 15:923-929.
35. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
36. Perera, P.-Y., S. A. Barber, L. M. Ching, and S. N. Vogel. 1994. Activation of LPS-inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary murine macrophages. Dissection of signaling pathways leading to gene induction and tyrosine phosphorylation. J. Immunol. 153:4684-1693.
37. Perera, P.-Y., N. Qureshi, and S. N. Vogel. 1996. Paclitaxel (Taxol)-induced NF-KB translocation in murine macrophages. Infect. Immun. 64:878-884.
38. Rewcastle, G. W., G. J. Atwell, B. C. Baguley, S. B. Calveley, and W. A. Denny. 1989. Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo. J. Med. Chem. 32:793-799.
39. Sakata, J., T. Shimokubo, K. Kitamura, S. Nakamura, K. Kangawa, H. Matsuo, and T. Eto. 1993. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:921-927.
40. Salkowski, C. A., G. Detore, R. McNally, N. van Rooijen, and S. N. Vogel. 1997. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J. Immunol. 158:905-912.
41. Salkowski, C. A., R. Neta, T. A. Wynn, G. Strassmann, N. van Rooijen, and S. N. Vogel. 1995. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J. Immunol. 155:3168-3179.
42. Shoji, H., N. Minamino, K. Kangawa, and H. Matsuo. 1995. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem. Biophys. Res. Commun. 215:531-537.
43. So, S., Y. Hattori, K. Kasai, S. Shimoda, and S. S. Gross. 1996. Up-regulation of rat adrenomedullin gene expression by endotoxin: relation to nitric oxide synthesis. Life Sci. 58:L309-L315.
44. Sugo, S., N. Minamino, K. Kangawa, K. Miyamoto, K. Kitamura, J. Sakata, T. Eto, and H. Matsuo. 1994. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 201:1160-1166. (Erra-tum, 203:1363, 1994.)
45. Sugo, S., N. Minamino, H. Shoji, K. Kangawa, K. Kitamura, T. Eto, and H. Matsuo. 1995. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 207:25-32.
46. Vogel, S. N. 1992. The Lps gene: insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation, p. 485-513. In B. Beutler (ed.). Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York, N.Y.
47. Walsh, T. J., A. Martinez, J. Peter, M. J. Miller, C. A. Lyman, J.-A. Bengoechea, T. Jacks, A. De Lucca, M. Rudel, T. H. Elsasser, E. J. Unsworth, and F. Cuttitta. Antimicrobial activities of adrenomedullin and its gene-related peptides. J. Biol. Chem., in press.
48. Zhang, X., V. E. Laubach, E. W. Alley, K. A. Edwards, P. A. Sherman, S. W. Russell, and W. J. Murphy. 1996. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/ interferon-gamma. J. Leukocyte Biol. 59:575-585.
49. Zhao, Y., S. Hague, S. Manek, L. Zhang, R. Bicknell, and M. C. Rees. 1998. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a nonestrogenic mechanism in the human endometrium. Oncogene 16:409-415.
50. Ziegler, E. J., C. J. J. Fisher, C. L. Sprung, R. C. Straube, J. C. Sadoff, G. E. Foulke, C. H. Wortel, M. P. Fink, R. P. Dellinger, and N. N. Teng. 1991. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N. Engl. J. Med. 324:429-436.